To protect the health and safety of the public and our employees, DCP has limited on-site staffing at 450 Columbus Blvd. While mail and phone calls will be processed as quickly as possible, we recommend using our online services, or sending an email to the appropriate division/person instead. We apologize for any inconvenience.

Synthetic Cannabis

Historically, a group of compounds originally developed by several medical/pharmacy researchers.

Currently there is no approved medical use for any of these products.

  • Classification: Hallucinogenic, marijuana-like, “ psychoactive designer drugs”

  • Availability:  Leafy plant material commonly sold in brightly colored foil packaging containing from 2 to 12 grams, or small plastic jars.  Sold in convenience stores, head shops and online

  • Observed Behavior: Expected marijuana-like high with negative effects

  • Observed negative effects: Anxiety, nausea, hypertension, severe paranoia, agitation, hallucinations, delusions, dilated pupils, heart palpitations, panic attacks, respiratory issues, heart attack, convulsions

  • Street Names:  
    • K-2
    • Spice
    • Black Mamba
    • Fake Weed
    • Genie
    • Blaze
    • JWH
    • Skunk

  • Street Pricing: Can be from a few dollars to twenty dollars per unit package

  • Drug Schedule: The synthetic cannabinmimetic compounds are Schedule I in Connecticut effective April 24, 2012
    • 21a-243-7(f) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of a substance having a psychotropic response primarily by agonist activity at cannabinoid-specific receptors affecting the central nervous system. Specific compounds include, but are not limited to:    
      • 1-pentyl-3-(1-naphthoyl)indole (JWH-018)
      • 1-butyl-3-(1-naphtholy)indole (JWH-073)
      • 1-[2-(4-morpholynyl)ethyl]-3-(1-naphthoyl)indole (JWH-200)
      • 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47497)
      • 5-(1,1-dimethylheptyl)-2-(1R,3S)-3-hydroxycyclohexyl]-phenol(cannabicyclohexanol CP-47,497 C* homologue). 
  • Charges: These drugs are  classified as Cannabinmimetic Agents in the Designer Drug-Hallucinogen Drug Type

    • Sale - Any quantity regardless of drug dependency is 21a-277(a)

    • Sale - Any quantity for a not drug dependent person is 21a-278(b)

    • Possession - Any quantity regardless of drug dependency 21a-279(b)